title: Chronic effects of methylmercury in rats. II. Pathological aspects.
abstract: Chronic effects of methylmercury (MeHg) were examined pathologically in male Wistar rats fed on diet containing 0, 1 or 5 ppm Hg (as MeHg) for two years. Organs including the central nervous tissues were examined histopathologically using hematoxylin and eosin (H & E), Klüver-Barrera (KB), PAS or phenol-congo red stains. The peripheral nerve system tissues were also examined, using H & E and trichrome stains. Furthermore, immunoglobulins of renal specimens were demonstrated by direct immunofluorescence microscopy. Localization of mercury in the paraffin-embedded sections of the nervous tissue, kidney, liver, pancreas, spleen and testis was demonstrable by the photoemulsion histochemical method. In the 5 ppm group, mercury was readily detectable in tissues of the rats exposed for one year, one and half years, two years and two and half years. Mercury was detected in the cells of the brain such as neurons, neuroglial cells, and phagocytes, and also in most organs, particularly in the epithelium of renal tubules, liver cells, myocardium, in the macrophages of pancreas, spleen and testis. In the 1 ppm group, mercury was detectable in the epithelium of renal tubules and liver cells. Fibrosis of the glomeruli was found in the rat group given a high dose of methylmercury with all experimental methods. Granular IgG, IgM and C3 deposits were demonstrated in the glomeruli by direct immunofluorescence microscopy. The etiology of the pathological changes of glomeruli was suspected to be autoimmune glomerulopathy due to inorganic mercury filtration for a long time. It was difficult to determine the clinical signs and symptoms and pathological changes in the nervous system in spite of the deposition of mercury in the brain.
authors.affiliation: National Institute for Minamata Disease, Japan.
authors.forename: K
authors.initials: K
authors.lastname: Eto
authors.forename: A
authors.initials: A
authors.lastname: Yasutake
authors.forename: K
authors.initials: K
authors.lastname: Miyamoto
authors.forename: H
authors.initials: H
authors.lastname: Tokunaga
authors.forename: Y
authors.initials: Y
authors.lastname: Otsuka
mesh_terms: D000284:Administration, Oral; D000818:Animals; D001921:Brain / Q000187:drug effects / Q000473:pathology; D002196:Capillaries / Q000737:chemistry / Q000473:pathology; D002540:Cerebral Cortex / Q000737:chemistry / Q000187:drug effects / Q000473:pathology; D005508:Food Deprivation; D005920:Glomerular Mesangium / Q000098:blood supply / Q000737:chemistry / Q000473:pathology; D007074:Immunoglobulin G / Q000032:analysis / Q000096:biosynthesis / Q000097:blood; D007150:Immunohistochemistry; D008297:Male; D008767:Methylmercury Compounds / Q000008:administration & dosage / Q000737:chemistry / Q000633:toxicity*; D009928:Organ Specificity / Q000187:drug effects* / Q000276:immunology; D051381:Rats; D017208:Rats, Wistar; D013997:Time Factors
chemical_list: D007074:Immunoglobulin G; D008767:Methylmercury Compounds